Free Newsletter
NYT: Sanctioned doctors paid to test therapies
Pouring through public records on file in Minnesota, The New York Times found more than 100 cases of physicians who were paid by drug companies to test therapies after they had been sanctioned by the state medical board for a variety of offenses, including the reckless disregard of their patients' welfare. Experts around the country say the only thing that makes Minnesota unusual is that it makes these documents public. Drug companies, they say, routinely engage physicians for drug testing who have run afoul of professional standards of conduct. According to the probe by the Times, 103 doctors disciplined or criticized by the state medical board collected $1.7 million in drug company fees. The largest group--39 doctors--had been sanctioned for inappropriate prescribing patterns. Thirty-eight of the doctors were receiving payments while under sanction. PhRMA declined comment on the report.
- read the investigative report from The New York Times
Related Articles:
Groups plan new fight to limit pharma-doctor ties. Report
Group: Few med schools free of pharma influence. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: